In cervical cancer patients who had undergone resection, the use of immunization with 13 overlapping long peptides spanning the entire sequence of HPV 16 E6 and E7 mixed with Montanide ISA 51 clearly revealed immunization-driven IFN-gamma production in enzyme-linked immunospot (ELISPOT) assay after completing the protocol [68]. This evidence concerns the gene IFNG and cervical carcinoma.